AXPH Stock Overview
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Alexandria Co. For Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ج.م316.78 |
52 Week High | ج.م319.99 |
52 Week Low | ج.م145.05 |
Beta | -0.066 |
11 Month Change | 32.69% |
3 Month Change | 44.50% |
1 Year Change | 91.70% |
33 Year Change | 106.47% |
5 Year Change | 195.26% |
Change since IPO | 871.73% |
Recent News & Updates
Recent updates
Shareholder Returns
AXPH | EG Pharmaceuticals | EG Market | |
---|---|---|---|
7D | 5.6% | 1.0% | 1.6% |
1Y | 91.7% | 43.1% | 34.3% |
Return vs Industry: AXPH exceeded the EG Pharmaceuticals industry which returned 42.8% over the past year.
Return vs Market: AXPH exceeded the EG Market which returned 33.8% over the past year.
Price Volatility
AXPH volatility | |
---|---|
AXPH Average Weekly Movement | 5.7% |
Pharmaceuticals Industry Average Movement | 6.4% |
Market Average Movement | 5.4% |
10% most volatile stocks in EG Market | 9.7% |
10% least volatile stocks in EG Market | 3.8% |
Stable Share Price: AXPH has not had significant price volatility in the past 3 months compared to the EG market.
Volatility Over Time: AXPH's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Mahmoud Rizk | www.alexcopharma.net |
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets, and distributes generic forms of human and animal health products in Egypt. It also offers medical appliances. The company is based in Alexandria, Egypt.
Alexandria Co. For Pharmaceuticals & Chemical Industries Fundamentals Summary
AXPH fundamental statistics | |
---|---|
Market cap | ج.م1.58b |
Earnings (TTM) | ج.م216.68m |
Revenue (TTM) | ج.م1.77b |
7.3x
P/E Ratio0.9x
P/S RatioIs AXPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AXPH income statement (TTM) | |
---|---|
Revenue | ج.م1.77b |
Cost of Revenue | ج.م1.37b |
Gross Profit | ج.م395.18m |
Other Expenses | ج.م178.50m |
Earnings | ج.م216.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 43.34 |
Gross Margin | 22.35% |
Net Profit Margin | 12.26% |
Debt/Equity Ratio | 0.1% |
How did AXPH perform over the long term?
See historical performance and comparisonDividends
9.5%
Current Dividend Yield23%
Payout RatioDoes AXPH pay a reliable dividends?
See AXPH dividend history and benchmarksAlexandria For Pharmaceuticals & Chemical Industries dividend dates | |
---|---|
Ex Dividend Date | Nov 18 2024 |
Dividend Pay Date | Nov 20 2024 |
Days until Ex dividend | 7 days |
Days until Dividend pay date | 9 days |
Does AXPH pay a reliable dividends?
See AXPH dividend history and benchmarks